Allergan Patents Spared From PTAB Review In Settlement
The Patent Trial and Appeal Board said it won't review six Allergan patents covering the company's injectable skin filler Juvederm, despite expressing skepticism toward them, after Allergan announced it has inked...To view the full article, register now.
Already a subscriber? Click here to view full article